In light of observations that CAIX activity has been linked to the capacity of tumor cells to migrate and grow, we questioned whether antibodies that are capable of blocking CAIX activity could limit RCC migration in vitro [29]. The gene discussed is CA9; the disease is renal cell carcinoma.